What is the primary purpose of levodopa in Parkinson's disease

A. To decrease acetylcholine levels: Levodopa does not directly affect acetylcholine. Parkinson’s disease involves dopamine deficiency, and acetylcholine modulation is a separate therapeutic target addressed by anticholinergic medications. B. To cure Parkinson's disease: Levodopa does not cure the disease or halt its progression. It temporarily restores dopamine activity to improve motor symptoms, but the underlying neurodegeneration continues. C. To reduce symptoms of anxiety: Anxiety may occur in Parkinson’s disease but is not directly treated by levodopa. Its main effect is on motor symptoms such as bradykinesia, rigidity, and tremors, not psychological symptoms. Other medications or interventions are used to manage anxiety. D. To increase dopamine levels in the brain: Levodopa is a dopamine precursor that crosses the blood-brain barrier and is converted to dopamine, replenishing the deficit caused by neuronal degeneration. Increasing central dopamine improves motor function and reduces Parkinsonian symptoms effectively.